The evaluation of serum samples obtained from 60 women with breast cancer revealed higher TPA serum levels in cases with more advanced disease (stage III and IV) than those with localized breast cancer (Table-IV) which indicates that high levels of TPA appear to be related to the tumor burden. This evidence concerns the gene PLAT and neoplasm.